Clinical trials
Type 2 Diabetes Patients clinical trials
Below are recruiting type 2 diabetes patients clinical trials, each written for real people, not researchers. We’re tracking 574 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07187830Recruiting
Semaglutide for belly fat and liver health in kidney disease
This study looks at whether semaglutide (a diabetes medication) affects belly fat and the liver in people who have both type 2 diabetes and chronic kidney disease. It aims to understand if the drug can improve these health markers even in patients with reduced kidney function.
Edmonton, AlbertaAges 18 years+ - NCT07121504Recruiting
Hybrid closed-loop insulin for blood sugar control during surgery
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
Changsha, HunanAges 18 years+ - NCT07075588Recruiting
Food and coaching to lower blood pressure for Black and Hispanic adults
This study tests a program that helps people manage their blood pressure by offering healthy food choices, personal diet coaching, and text messages that match your culture. It's for Black/African American or Hispanic/Latino adults living in certain low-income areas of Maryland.
Baltimore, MarylandAges 21–70 - NCT07053293RecruitingEarly Phase 1
Study on diabetes medication and liver sugar production
This study tests how a type of diabetes medicine called SGLT2 inhibitors affects how the liver makes sugar. It may help researchers better understand how to manage blood sugar in people with type 2 diabetes.
San Antonio, TexasAges 30–75 - NCT07053306RecruitingPhase 1
Study of SGLT2 inhibitor effects on ketoacidosis risk
This study looks at how stopping a common diabetes drug (SGLT2 inhibitor) affects the body's risk of a serious condition called ketoacidosis. It may help understand who is most at risk and how to prevent it.
San Antonio, TexasAges 30–75 - NCT06942195Recruiting
Calcium's effect on gut function and blood sugar in type 2 diabetes
This study tests if calcium can help control blood sugar and gut function in men with type 2 diabetes. You'll take calcium or a placebo and have a tube inserted into your stomach to measure digestion.
Adelaide, South AustraliaAges 18–70 - NCT06831162Enrolling by invitation
Study on addressing health needs in diabetes care
This study looks at whether connecting people with type 2 diabetes, along with high blood pressure or high cholesterol, to resources for needs like food or housing can improve their health. It uses information from a screening questionnaire and may ask some patients to complete a survey.
Nashville, TennesseeAges 18 years+ - NCT06782139RecruitingPhase 4
Enavogliflozin for heart health in obesity and diabetes
This trial tests if Enavogliflozin, a medication for diabetes, can improve blood flow in the small vessels of the heart and overall heart function in people with obesity or diabetes. You may join if you have obesity or diabetes and have had a recent heart test.
SeoulAges 20–79 - NCT06768177Enrolling by invitation
Platelet-Rich Plasma for Erectile Dysfunction
This trial tests if injecting platelet-rich plasma (PRP) into the penis can improve erectile function in men who haven't had success with other treatments. It may be an option if you have moderate to severe ED, have tried other therapies, or have had pelvic surgery.
BariAges 30 years+ - NCT06752772Recruiting
Wearable health coaching for blood pressure and weight
This study tests a digital health coaching program that uses a smartwatch and smartphone to help people manage conditions like high blood pressure, pre-diabetes, or weight. It aims to see if wearable technology can improve your health with personalized coaching.
SingaporeAges 21–75 - NCT06169033Recruiting
Can belly fat scans predict weight-loss surgery success?
This study looks at how fat around your belly and inside your abdomen, seen on a CT scan, can predict how well bariatric (weight-loss) surgery will work for people with type 2 diabetes.
BeijingAges 16–70 - NCT06682481Recruiting
Pancreas-Liver Communication in Teens with Obesity
This study looks at how the pancreas and liver talk to each other in teens with obesity. It may help understand why some teens develop diabetes or fatty liver.
Geneva, Canton of GenevaAges 12–16 - NCT06671587RecruitingPhase 4
Testing insulin/GLP-1 combo with CGM for type 2 diabetes
This study tests a combination insulin/GLP-1 medicine (iGlarLixi) with continuous glucose monitoring to see how well it controls blood sugar in Chinese adults with type 2 diabetes. It may help those whose current pills are not working enough.
BeijingAges 18 years+ - NCT06647745RecruitingPhase 3
Study for type 2 diabetes and high blood pressure
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
SeoulAges 19 years+ - NCT06614101Recruiting
Breath test for monitoring blood sugar
This study is testing a new device that measures blood sugar levels by analyzing your breath. It is for people with type 2 diabetes or those who are overweight, to see if the breath test can work as a non-invasive way to monitor glucose.
Salies-du-Salat, FranceAges 18 years+ - NCT06567990Recruiting
Type 2 diabetes and fatty liver: new tests for disease tracking
This study is looking for people with type 2 diabetes and fatty liver disease to find better ways to track how the disease progresses. They will use special tests (biomarkers) to see if the liver is getting worse over time.
DijonAges 40–80 - NCT06546085Recruiting
Extracellular vesicles, insulin, and exercise in type 2 diabetes
This study looks at how tiny particles called extracellular vesicles affect how your body uses insulin, and whether exercise can make a difference. It is for people with type 2 diabetes (or normal blood sugar) who are not very active and have been on diabetes medication for a long time.
New Brunswick, New JerseyAges 30–80 - NCT06399835RecruitingPhase 4
Comparing two diabetes drugs for blood sugar and heart health
This study tests a new diabetes medicine called Enavogliflozin against an older drug, Pioglitazone, to see which works better for lowering blood sugar and improving heart health. If you have type 2 diabetes, take metformin plus another pill, and your A1C is between 7 and 10.5, this study may be an option for you.
Seongnam-si, Gyeonggi-doAges 20–80 - NCT06402747RecruitingPhase 4
Comparing clopidogrel vs cilostazol for diabetes-related artery thickening
This trial compares two blood-thinning drugs (clopidogrel and cilostazol) to see which one better prevents artery problems in people with diabetes and thickened carotid arteries. It may help you if you have diabetes and are already on stable medications.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT06322212RecruitingEarly Phase 1
Type 2 diabetes and brain blood barrier study
This study tests if a treatment can improve the blood-brain barrier in adults with type 2 diabetes. It uses MRI scans to see changes and may help protect brain function.
Los Angeles, CaliforniaAges 40–65 - NCT06143566RecruitingPhase 1/Phase 2
Polypill to prevent heart failure in diabetes and kidney disease
This trial tests a 'polypill' (a combination of several medicines in one pill) to prevent heart failure in people with type 2 diabetes and kidney disease. It may help reduce your risk of developing heart muscle problems.
Dallas, TexasAges 18–100 - NCT05960656RecruitingPhase 1
Study of SGLT2 inhibitor effects on liver sugar production
This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.
San Antonio, TexasAges 30–75 - NCT05933161Recruiting
Testing diabetes blood-sugar tracking for people with an LVAD
This study looks at how well people with an LVAD can manage their blood sugar when they use a continuous glucose monitor app on a smartphone. It may help your diabetes care team adjust treatment using more complete sugar data.
Rochester, MinnesotaAges 18 years+ - NCT05881447Recruiting
Study kidney disease patterns in people in Tanzania
This study looks at how common chronic kidney disease is, how it develops over time, and what risk factors are linked to it. It may help improve how kidney disease is recognized and managed in your community.
Bagamoyo, Coast RegionAges 18–99
Hear when a new Type 2 Diabetes Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes patients?
- Yes. Clin2 currently lists 574 recruiting type 2 diabetes patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.